The vibrating platform could be useful for growing artificial muscles to power soft robots and testing therapies for neuromuscular diseases.

New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.

By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.

Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.

MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.

In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.

SMART researchers find the enzyne RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.

MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.

BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.

The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.